Amgen Inc data breach

Clerk's notes

Amgen Inc, a prominent biotechnology and pharmaceutical company, reported a data security incident to the Indiana Attorney General on August 17, 2026. This breach, which Amgen states was discovered on July 1, 2026, is currently under regulatory monitoring.

The compromised data reportedly includes Full Name, Date of Birth, Social Security Number, Clinical Trial Participation Records, Medical History and Treatment Information, Health Insurance ID Number, Mailing Address, and Email Address. The exposure of such a broad range of sensitive data creates significant risks, from medical identity theft, which can lead to fraudulent claims and incorrect medical records, to financial identity theft stemming from Social Security Number exposure.

As a company entrusted with highly confidential patient and personal data, Amgen Inc is subject to stringent legal requirements to protect this information, including federal and state privacy laws. The occurrence of a breach suggests potential failures in upholding these mandated security protocols, which are designed to safeguard sensitive information from unauthorized access.

If you have received an official data breach notification letter from Amgen Inc, it serves as formal confirmation that your confidential information was compromised. Receiving this letter establishes your standing to seek legal recourse. Our firm is currently investigating this data breach on a contingency fee basis; there are no out-of-pocket costs or upfront legal fees, and we only receive compensation if we successfully recover damages. We invite affected individuals to request a free case review to understand their legal options.

If a notification letter about this breach reached you, see every Indiana data breach on file or browse all cases.